Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent
2006-02-07
2006-02-07
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S490000, C548S491000
Reissue Patent
active
RE038970
ABSTRACT:
A heterocyclic derivative of the formula (I)wherein each symbol is as defined in the specification, and pharmaceutically acceptable salts thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof exhibit superior ACAT inhibitory activity and lipoperoxidation inhibitory activity in mammals, and are useful as ACAT inhibitors and lipoperoxidation inhibitors. Specifically, they are useful for the prophylaxis and treatment of arteriosclerosis, hyperlipemia, arteriosclerosis in diabetes, and cerebrovascular and cardiovascular ischemic diseases.
REFERENCES:
patent: 4803218 (1989-02-01), Stanley et al.
patent: 5153226 (1992-10-01), Chucholowski et al.
patent: 5219859 (1993-06-01), Festal et al.
patent: 5254565 (1993-10-01), Meguro et al.
patent: 5254590 (1993-10-01), Malen et al.
patent: 5356920 (1994-10-01), Cozzi et al.
patent: 5609649 (1997-03-01), Junino et al.
patent: 5952354 (1999-09-01), Commons et al.
patent: 5990150 (1999-11-01), Matsui et al.
patent: 6127403 (2000-10-01), Matsui et al.
patent: 2 029 660 (2002-01-01), None
patent: 0 325 397 (1989-07-01), None
patent: 0 354 994 (1990-02-01), None
patent: 0 375 113 (1990-06-01), None
patent: 0 447 116 (1991-09-01), None
patent: 0 472 116 (1992-02-01), None
patent: 0 512 570 (1992-11-01), None
patent: 0 635 501 (1994-07-01), None
patent: 622356 (1994-11-01), None
patent: 0 622 356 (1994-11-01), None
patent: 0 708 091 (1996-04-01), None
patent: 0 782 986 (1997-07-01), None
patent: 0 793 140 (1997-09-01), None
patent: 9202462 (1992-06-01), None
patent: 210861 (1995-08-01), None
patent: 216790 (1999-08-01), None
patent: 2-117651 (1990-05-01), None
patent: 3-7259 (1991-01-01), None
patent: 3-148247 (1991-06-01), None
patent: 4-66568 (1992-03-01), None
patent: 4-234839 (1992-08-01), None
patent: 4-327564 (1992-11-01), None
patent: 5-32666 (1993-02-01), None
patent: 5-97802 (1993-04-01), None
patent: 5-140102 (1993-06-01), None
patent: 8-92210 (1996-04-01), None
patent: 8-208602 (1996-08-01), None
patent: 96/09287 (1996-03-01), None
“Potential Antiatheroscelerotic Agents. 5.1An acyl-CoA:Cholesterol O-Acyltransferase Inhibitor with Hypocholesterolemic Activity”, J. Med. Chem. vol. 29, pp. 1131-1133. 1986.
K. Yee et al., “Novel Series of Selective Leukotriene Antagonists: Exploration and Timization of the Acidic Region in 1,6-Disubstituted Indoles and Indazoles”, Journal of Medicinal Chemistry, vol. 33, No. 9, pp. 2437-2451, 1990.
V. Matassa et al., “Evolution of a Series of Peptidoleukotriene Antagonists: Synthesis and Structure/Activity Relationships of 1,3, 5-substituted Indoles and Indazoles”, Journal of Medicinal Chemistry, vol. 33, No. 6, pp. 1781-1790, 1990.
F. Brown et al., “Evolution of a Series of Peptidoleukotriene Antagonists: Synthesis and Structure-Activity Relationships of 1,6-Disubstituted Indoles and Indazoles”, Journal of Medicinal Chemistry, vol. 33, No. 6, pp. 1771-1781, 1990.
Communications to the Editor, “Potential Antiatheroscelerotic Agents. 5.1An acyl-CoA:Cholesterol O-Acyltransferase Inhibitor with Hypocholesterolemic Activity”, J. Med. Chem. vol. 29, pp. 1131-1133 (1986).
Yee et al., “A Novel Series of Selective Leukotriene Antagonists: Exploration and Timization of the Acidic Region in 1,6-Disubstituted Indoles and Indazoles”, Journal of Medicinal Chemistry, vol. 33, No. 9, pp. 2437-2451 (1990).
Matassa et al., “Evolution of a Series of Peptidoleukotriene Antagonists: Synthesis and Structure/Activity Relationships of 1,3, 5-substituted Indoles and Indazoles”, Journal of Medicinal Chemistry, vol. 33, No. 6, pp. 1781-1790 (1990).
F. Brown et al., “Evolution of a Series of Peptidoleukotriene Antagonists: Synthesis and Structure-Activity Relationships of 1,6-Disubstituted Indoles and Indazoles”, Journal of Medicinal Chemistry, vol. 33, No. 6, pp. 1771-1781 (1990).
Kamiya Shoji
Matsui Hiroshi
Nakamura Shohei
Shirahase Hiroaki
Wada Katsuo
Frishauf Holtz Goodman & Chick P.C.
Kyoto Pharmaceutical Industries, Ltd.
Rao Deepak
LandOfFree
Indolyl or indolinyl derivatives and medicinal use thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolyl or indolinyl derivatives and medicinal use thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolyl or indolinyl derivatives and medicinal use thereof... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3688151